Navigation Links
Yongye International Announces Opening of New Production Facility
Date:8/30/2010

ooey, Senior Vice President at NASDAQ; Mr. Zhao Zekun, Chief Editor of CCTV's Agriculture Channel; Mr. Tao Yuanjie, President of Farmer's Daily; Mr. Qu Zhenyuan, President of China Agricultural University; and other dignitaries and guests.

"The opening of our second production facility is an important milestone in our business development," stated Mr. Wu. "Our last factory expansion in Hohhot was completed in October of 2008. Over the last two years our company has experienced tremendous growth. This growing demand is a testament to the effectiveness of both our scalable business model and the ability of our Shengmingsu plant nutrient product in helping farmers increase crop yields, thereby providing them with a compelling return on investment. We continue to see strong sales growth in our traditionally strong provinces as well as in the newer provinces of Central and Southern China which have recently added Yongye branded stores. We expect the new production facility to provide significant support to our continuous business expansion throughout China in the next several years."

About Yongye International

Yongye International is a Chinese agricultural nutrient company headquartered in Beijing, with its production facilities located in Hohhot, Inner Mongolia, China. Yongye markets two lines of organic nutrient products: a liquid nutrient product which is sprayed on plants and a powder nutrient product which is added to animal feed. Both products are sold under the brand name "Shengmingsu," which means "life essential" in Chinese. The Company's patented and patent pending formulas and proprietary extraction processes allow it to create products that increase crop yields and improve the health of livestock. The Company sells its products primarily to provincial or regional level distributors, who then channel those products to a carefully selected network of independently-owned Yongye branded stores in China. For more information, please visit t
'/>"/>

SOURCE Yongye International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Yongye International Announces Completion of Restructuring
2. Award-Winning U.S. Talk Show Host Montel Williams Joins Rex Bionics New International Advisory Board
3. PRA International to Exhibit at ESCs Annual Conference
4. International Research Team Closes In On Cause of Common Form of Muscular Dystrophy
5. OXIS International, Inc. Announces Publication of Positive Results of Ergothioneine Safety Study in the Journal TOXICOLOGY
6. Boston Scientifics Womens Health Products Featured in Studies at the Joint Annual Meeting of the International Continence Society and International Urogynecological Association
7. China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010
8. PRA International Hosts Audio Conference on CV Drug Development
9. Dyadic International Reports 2010 Second Quarter Financial Results
10. Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010
11. Chindex International to Report First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... STAAR Surgical Company (NASDAQ: STAA ), a leading developer, ... the eye, today announced that its Board of Directors has ... Mr. Wall was formerly the General Counsel ... firm, for more than nine years. Mr. Wall is currently ... the Corporate Governance Committee and member of the Audit Committee, ...
(Date:9/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ) ... Delivery (London, UK - November 19-20, 2015)" conference ... meeting will cover industry case studies, regulatory updates, latest ... are Dr Steven Nichols , OINP Specialist Consultant ... Companies participating include: - ...
(Date:9/2/2015)... 2015   Gulf Coast Tattoo Removal is the first ... Astanza Duality laser in Southern Mississippi . Gulf ... regret and take back control of their skin. The clinic is ... services to Biloxi , Gulfport ... regret being as prevalent as it is, I was surprised by ...
Breaking Medicine Technology:William P. Wall Appointed to STAAR Surgical Board of Directors 2Gulf Coast Tattoo Removal Delivers Unrivaled Tattoo Removal Results To Biloxi And Gulfport With Astanza Duality 2
... FDA for Stand-Alone Therapy in Q1 2008, SAN ... ) and Eli Lilly and Company (NYSE: LLY ... with type 2 diabetes who were,unable to achieve glycemic ... either monotherapy (stand-alone) BYETTA(R) (exenatide),injection taken twice daily or ...
... Company to Continue Focus on Pipeline and Haptoglobin ... Synvista Therapeutics,Inc. (Amex: SYI ) today announced ... and 203) of SYI-2074 in Type 2 diabetic ... target of Synvista,s,proprietary haptoglobin variant test currently under ...
Cached Medicine Technology:Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 2Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 3Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 4Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 5Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 6Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 7Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease 2Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease 3Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease 4
(Date:9/2/2015)... Alexandria, VA (PRWEB) , ... ... ... Sept. 9, the 2015 Warrior-Family Symposium (WFS), cosponsored by the Military Officers ... in Washington. During the event, "Our Nation's Military: Caring For Our Own,” ...
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, a ... the two leaders who will deliver keynote presentations at the upcoming Digital Healthcare ... Oriental Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver the ...
(Date:9/2/2015)... CA (PRWEB) , ... September 02, 2015 , ... According to an article ... California Governor Jerry Brown that aims to do away with grand juries in cases meant ... duty. Passed as a direct response to grand jury decisions in Ferguson and New York ...
(Date:9/2/2015)... ... ... Based in Beverly Hills, Luxury Line Auto Rental explains that they are ... of the latest and greatest vehicles their customers want to drive the most. Now, ... a 2015 Rolls Royce Wraith rental in Los Angeles is now available ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Telehealth represents ... Well Corp., contracted to handle the telehealth services of more than 12 Blues plan ... and Blue Shield Plans takes a look this growing trend, interviewing executives at Capital ...
Breaking Medicine News(10 mins):Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 3
... North America -, PRINCETON, N.J., Dec. 18 ... Barr has been named Covance,s Chief,Operating Officer, effective ... of Early Development North America, will assume operating,responsibility ... to,Joe Herring, Covance,s Chairman and Chief Executive Officer. ...
... slightly more effective than traditional lung scans, , , TUESDAY, ... a life-threatening blood clot in the lungs -- can ... a technique using CT scanning might be slightly more ... Canadian researchers found that computed tomographic pulmonary angiography (CTPA) ...
... team of researchers led by Mayo Clinic have designed a ... to destroy cancer cells that spread from primary tumors to ... addition, their study shows that this technology could be the ... , The study appeared in the Dec. 9 online issue ...
... screenings for those with severe illnesses, they may bring ... a recent study by Yale School of Medicine researchers ... study offers a new approach for assessing who is ... recommendations can be tailored more effectively to individual patients. ...
... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), ... and hospitals throughout the United States,today announced that ... Healthcare,Conference, January 10, 2008, at 8:30 a.m. PST ... Paul Berger, Chairman and CEO, Tim Mayleben, President,and ...
... Dec. 18 Psoriasis Cure Now,a nonprofit patient ... an association between severe psoriasis and a significantly,increased ... psoriasis research. The,study, by a team of University ... severe psoriasis have a 50 percent,increased risk of ...
Cached Medicine News:Health News:Wendel Barr Appointed Chief Operating Officer of Covance 2Health News:Wendel Barr Appointed Chief Operating Officer of Covance 3Health News:CT Scans Catch More Clots in Lungs 2Health News:CT Scans Catch More Clots in Lungs 3Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 2Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 3Health News:Colon cancer screenings may not pay off and could pose harm to some 2Health News:NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008 2
Histopathology Reference Laboratory provides a full range of histology services, encompassing routine and specialized grossing, processing, embedding, microtomy, routine and special staining and cove...
IBT Reference Laboratory is a national research and specialty clinical lab founded in 1983 that provides a wide range of tests and services in the area of allergy, clinical immunology and molecular b...
Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom...
Headquartered in Burlington, North Carolina, LabCorp has more than 23,500 employees and offers more than 4,400 clinical tests ranging from routine blood analyses to the most sophisticated molecular d...
Medicine Products: